News

Exosomes vs polynucleotides UK, what patients need to know

Skin rejuvenation treatments can sound similar but behave differently in real life. Two options often discussed are exosomes and polynucleotides (often described as PDRN-style treatments). Both aim to support skin quality, yet they differ in what they contain, how they are used, and what is currently considered appropriate and safe in the UK.

This guide explains the basics in plain English, compares which concerns each may suit best, and sets realistic expectations around sessions, timelines, downtime, and UK legal and safety considerations.

What are exosomes in aesthetics?

In simple terms, exosomes are tiny messenger particles released by cells. They can carry proteins, lipids, and genetic signals that influence how cells communicate. In regenerative medicine research, exosomes are being explored for wound healing and tissue repair.

In aesthetics, the most common patient-facing approach in the UK is topical use after a procedure that creates micro-channels in the skin, such as:

• Microneedling
• RF microneedling
• Laser resurfacing (where clinically appropriate)

The idea is that after controlled skin stimulation, topical exosome-containing products may support recovery and improve the look of skin quality. Evidence is emerging, product quality varies, and outcomes depend heavily on the underlying procedure, skin type, and realistic goals.

What are polynucleotides and PDRN?

Polynucleotides are DNA fragments (commonly derived from fish sources) used in medical aesthetics to support hydration, elasticity, and skin texture. Many clinics use them as injectable skin boosters in specific layers of the skin.

PDRN is a related term often used to describe DNA-derived regenerative ingredients. Not all products are identical, and naming can be inconsistent. What matters clinically is:

• The product’s regulated status and supply chain
• How it is intended to be used (injectable vs topical)
• Practitioner training and patient suitability

Polynucleotides are generally positioned for skin quality, crepey texture, and delicate areas, rather than pigment-only concerns.

UK legality and safety, topical vs injectable

Regulation and product sourcing matter because these treatments are sometimes marketed online with claims that do not match UK clinical standards.

Exosomes in the UK

In the UK, injectable exosome products are a legal and regulatory grey area. Many are not authorised medicines, and their sourcing, sterility, and manufacturing standards can be difficult to verify.

For patient safety, many reputable UK clinics limit exosomes to topical, post-procedure use with appropriately sourced products, rather than injecting them.

Key safety points:

• Ask what the product is, where it is sourced from, and whether it is intended for topical use.
• Be cautious of strong claims, especially if a provider suggests injecting exosomes.
• If you are prone to pigmentation (melasma) or inflammation, your treatment plan should prioritise barrier protection and low-risk protocols.

Polynucleotides in the UK

Polynucleotide injectables are commonly used in UK medical aesthetics. Safety still depends on:

• Appropriate patient selection
• Correct injection technique and anatomy knowledge
• Sterile practice and aftercare

Important practical considerations:

• If you have a fish allergy, you must tell your clinician, as some polynucleotide products are fish-derived.
• If you are pregnant or breastfeeding, treatment is usually deferred.

Which is better for pigmentation, redness, acne scars and crepey skin?

No single treatment is best for everyone. A useful way to decide is to match the option to your primary concern and your skin’s tolerance for inflammation.

At-a-glance comparison

Concern	Exosomes (commonly topical post-procedure)	Polynucleotides (injectable skin booster)
Pigmentation, uneven tone	May support recovery and reduce post-procedure downtime when paired with microneedling or laser, not a stand-alone pigment treatment	May improve overall skin quality, but usually not first-line for pigment-only issues
Redness, reactive skin	Some patients seek them post-procedure to calm recovery, suitability varies	Often chosen for barrier support and texture, may suit delicate, crepey skin, not a rosacea cure
Acne scars (atrophic)	Can be an adjunct after collagen-stimulating procedures	Can support skin quality, but deep scars usually need targeted scar treatments
Crepey skin, fine texture	May help post-procedure recovery and skin finish	Often a strong match for crepey texture and thin skin, especially under eyes and neck
Under-eye quality	Usually used as topical adjunct after energy-based or needling treatments	Commonly used for under-eye crepiness and fine lines, careful technique is essential

Pigmentation and uneven tone

Pigmentation can mean sun spots, post-inflammatory hyperpigmentation (PIH), or melasma. These behave differently.

• If you are prone to PIH, the priority is reducing inflammation and using a plan that respects your skin barrier.
• Exosomes, when used topically after microneedling or laser (if appropriate), may help the skin recover more smoothly. This can be helpful when pigmentation is aggravated by inflammation.
• Polynucleotides can improve hydration and texture, which may make tone look more even, but they are not typically a primary pigment treatment.

Best practical approach in clinic is often a combination of:

• Strict daily SPF
• A tailored topical regimen (for example pigment modulators where suitable)
• Procedural options chosen carefully for your skin type

Redness, rosacea-prone or sensitive skin

Redness has multiple causes including barrier impairment, rosacea, post-acne inflammation, and broken capillaries.

• Polynucleotides are frequently selected to support skin quality in delicate or easily irritated skin, aiming for better hydration and texture over time.
• Exosomes are sometimes used topically after procedures to support recovery, but the right choice depends on what triggered the redness in the first place.

Important: neither treatment should be presented as a cure for rosacea. If you flush easily, react to products, or have visible vessels, you may need a medical assessment first.

Acne scars

For true acne scarring (especially depressed, tethered scars), the most effective results usually come from scar-specific procedures, such as:

• Subcision for tethered scars
• Microneedling or RF microneedling for collagen stimulation
• Fractional laser where clinically appropriate

In that context:

• Exosomes (topical) may be used as an adjunct to support recovery after collagen-stimulating procedures.
• Polynucleotides (injectable) may improve overall skin quality and hydration, helping the surface look smoother, but they will not replace targeted scar work for deeper scars.

Crepey skin and fine texture

Crepey skin often reflects reduced collagen, elastin, and hydration, commonly around the eyes, neck, and lower face.

• Polynucleotides are often a strong match for crepey texture because they are used specifically to support skin quality and elasticity over a course of sessions.
• Exosomes may be considered as a supportive add-on after procedures that stimulate collagen, especially if downtime reduction is a priority.

If crepiness is driven by significant skin laxity, you may need to discuss other options as well, as boosters alone may give only subtle improvement.

Under-eye concerns

Under-eye skin is thin, reactive, and prone to swelling.

• Polynucleotides are commonly used under the eyes to improve fine crepiness and skin quality. Technique matters, and not everyone is suitable.
• Exosomes are more often positioned as topical support after needling or energy-based treatments rather than a stand-alone under-eye injectable.

If your main issue is hollowness or prominent eye bags, you may need a different plan. Treating the wrong problem can worsen the appearance.

Treatment plan expectations

### How many sessions and how often?
Protocols vary by product and skin concern, but typical planning looks like:

• Polynucleotides: often 2 to 4 sessions, spaced about 2 to 4 weeks apart, then maintenance every 4 to 9 months depending on skin goals.
• Exosomes (topical adjunct): commonly used alongside a course of microneedling or similar procedures, for example 3 sessions spaced 4 weeks apart, aligned to the primary treatment schedule.

Your clinician should tailor this based on skin sensitivity, pigmentation risk, and whether acne is active.

When will I see results?

Skin quality treatments tend to be gradual.

• Early changes (hydration, glow) may be noticed in 1 to 3 weeks.
• Texture, fine lines, and scar softening typically take 6 to 12 weeks, as collagen remodelling is slow.
• Pigmentation changes often require consistent homecare and may take several months.

No ethical clinic can guarantee outcomes, particularly for melasma, rosacea, and deep scarring.

Downtime and aftercare

Downtime depends more on the delivery method (needling, laser, injection technique) than on the product name.

Typical downtime

• Polynucleotide injections: small bumps, redness, and mild swelling are common for 24 to 72 hours. Bruising can occur.
• Microneedling with topical exosomes: redness and tightness are common for 24 to 72 hours, occasionally longer with stronger treatments.

Aftercare basics

• Avoid heat exposure, heavy exercise, and alcohol for 24 to 48 hours (or as advised).
• Keep skincare gentle for several days, avoid strong acids and retinoids until your clinician says it is safe.
• Use broad-spectrum SPF daily, especially if pigmentation is a concern.
• Do not pick or scrub flaking skin.

Who should avoid treatment or seek medical advice first?

You should have a medical assessment first if you:

• Are pregnant or breastfeeding
• Have a history of severe allergies or anaphylaxis
• Have a fish allergy (relevant to some polynucleotide products)
• Have an active skin infection, cold sore outbreak, or inflamed acne flare
• Have uncontrolled rosacea, eczema, or dermatitis
• Are on blood thinners or bruise easily
• Have a history of keloid scarring (needling and some procedures may be unsuitable)
• Have melasma, as treatment requires careful planning to avoid worsening pigmentation

Always disclose medical history and current medications, including isotretinoin history and immune-suppressing therapies.

So, which is better?

For many UK patients, a practical way to think about it is:

• If your priority is crepey skin, under-eye texture, and overall skin quality, polynucleotides are often the more direct option.
• If your priority is supporting recovery after microneedling or laser, topical exosomes may be considered as an adjunct, provided the product is appropriately sourced and used within UK standards.
• For pigmentation and acne scarring, both may play supporting roles, but results usually depend on a broader plan including the right device-based treatment and consistent skincare.

The safest and most effective approach starts with diagnosis, especially for redness and pigmentation, where the wrong procedure can make things worse.

Next step

If you are considering exosomes vs polynucleotides UK options, an in-person assessment helps clarify what is driving your pigmentation, redness, acne scarring, or crepey texture, and what is realistic for your skin. Patients can be assessed by experienced medical professionals at Renovatio Clinic.